Insights

Innovative Technology Emulate's pioneering Organ-on-a-Chip technology offers a highly accurate human tissue replication platform, making it an attractive solution for pharmaceutical and biotech companies seeking advanced in vitro models to improve preclinical testing and reduce animal testing.

Strong Market Presence With recent product launches like the AVA Emulation System and Chip-R1 Rigid Chip, along with awards such as the SLAS New Product Award, Emulate demonstrates ongoing innovation and emerging leadership, providing opportunities to partner or upsell with organizations seeking cutting-edge research tools.

Robust Financial Position Supported by over 352 million dollars in funding and generating approximately 25 to 50 million dollars in revenue, Emulate has the financial strength to expand its product offerings and invest in sales channels targeting large pharmaceutical and academic institutions.

Strategic Industry Recognition Being listed among Fast Company’s most innovative companies in 2022 bolsters Emulate’s credibility, making it easier to engage with top-tier research institutions and biotech firms interested in innovative partnership opportunities.

Expanding Product Portfolio The launch of specialized products like the Zoë-CM2 Culture Module and AVA System indicates a focus on broadening applications within disease modeling and tissue research—presenting sales opportunities for related consumables, upgrades, and complementary research accessories.

Similar companies to Emulate, Inc.

Emulate, Inc. Tech Stack

Emulate, Inc. uses 8 technology products and services including Twemoji, ADP HRMS, Backbone.js, and more. Explore Emulate, Inc.'s tech stack below.

  • Twemoji
    Font Scripts
  • ADP HRMS
    Human Resource Management System
  • Backbone.js
    Javascript Frameworks
  • Python
    Programming Languages
  • Adobe Acrobat DC
    Rich Text Editors
  • YouTube
    Video Players
  • Vimeo
    Video Players
  • React Native
    Widgets

Media & News

Emulate, Inc.'s Email Address Formats

Emulate, Inc. uses at least 1 format(s):
Emulate, Inc. Email FormatsExamplePercentage
First.Last@emulatebio.comJohn.Doe@emulatebio.com
89%
FLast@emulatebio.comJDoe@emulatebio.com
5%
Last@emulatebio.comDoe@emulatebio.com
5%
First@emulatebio.comJohn@emulatebio.com
1%

Frequently Asked Questions

Where is Emulate, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Emulate, Inc.'s main headquarters is located at Boston, Massachusetts 02210 United States. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Emulate, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Emulate, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Emulate, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Emulate, Inc.'s official website is emulatebio.com and has social profiles on LinkedInCrunchbase.

What is Emulate, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Emulate, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Emulate, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Emulate, Inc. has approximately 78 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. C.VP For Research: K. K.Co-Founder, Chief Technology Officer And Board Member: D. L.. Explore Emulate, Inc.'s employee directory with LeadIQ.

What industry does Emulate, Inc. belong to?

Minus sign iconPlus sign icon
Emulate, Inc. operates in the Biotechnology Research industry.

What technology does Emulate, Inc. use?

Minus sign iconPlus sign icon
Emulate, Inc.'s tech stack includes TwemojiADP HRMSBackbone.jsPythonAdobe Acrobat DCYouTubeVimeoReact Native.

What is Emulate, Inc.'s email format?

Minus sign iconPlus sign icon
Emulate, Inc.'s email format typically follows the pattern of First.Last@emulatebio.com. Find more Emulate, Inc. email formats with LeadIQ.

How much funding has Emulate, Inc. raised to date?

Minus sign iconPlus sign icon
As of March 2026, Emulate, Inc. has raised $352M in funding. The last funding round occurred on Sep 07, 2021 for $82M.

When was Emulate, Inc. founded?

Minus sign iconPlus sign icon
Emulate, Inc. was founded in 2014.

Emulate, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, enabling researchers to accurately replicate human tissue function and disease biology through next generation in vitro models. From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate’s Organ-Chip platforms, consumables, and organ models help the world’s leading pharmaceutical, biotech, and academic teams generate human-relevant data that advance safer, more effective therapies.

Section iconCompany Overview

Headquarters
Boston, Massachusetts 02210 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $352M

    Emulate, Inc. has raised a total of $352M of funding over 4 rounds. Their latest funding round was raised on Sep 07, 2021 in the amount of $82Mas a Series E.

  • $25M$50M

    Emulate, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $352M

    Emulate, Inc. has raised a total of $352M of funding over 4 rounds. Their latest funding round was raised on Sep 07, 2021 in the amount of $82Mas a Series E.

  • $25M$50M

    Emulate, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.